What is Guardant Health (GH)?
Guardant Health is a precision oncology company specializing in the development and commercialization of blood-based tests for cancer detection and management. The company focuses on liquid biopsy technologies that analyze circulating tumor DNA to provide insights into tumor genetics and help guide treatment decisions. Guardant Health's products are used by oncologists to support personalized cancer care, including identifying actionable mutations and monitoring disease progression or recurrence. The company collaborates with pharmaceutical companies, research institutions, and healthcare providers to advance cancer diagnostics and improve patient outcomes. Guardant Health operates within the broader field of molecular diagnostics and precision medicine, aiming to offer minimally invasive alternatives to traditional tissue biopsies. Its technologies contribute to the evolving landscape of cancer care by enabling earlier detection and more targeted therapeutic approaches.
Guardant Health Stock Price Today: Live Overview
The price today is shaped by market fluctuations, with Guardant Health priced at $86.69. Price movements today have ranged from $83.95 to $89.02, representing a daily change of +3.8019%.
FAQ: Guardant Health (GH)
What is the current price of GH stock?
The latest price recorded is $86.69.
Does GH pay dividends?
Guardant Health does not pay dividends.
Does GH have a formal corporate presence or regional headquarters in the UAE?
Guardant Health operates in the UAE only through partners and distributors without a direct regional office.
What is GH best known for?
The company is most famous for its liquid biopsy tests for cancer detection.
What assets are typically shown together with GH?
Commonly shown alongside GH: Capital Southwest, Post Holdings, Polynovo Limited
Latest shares articles



